“I’m proud that the FTC launched a bipartisan investigation into these shadowy middlemen, and its preliminary findings prove yet again that it’s time to bust up the PBM monopoly.” A US ...
The FTC's long-awaited report published in July was a difficult read for the PBM industry, concluding that the six largest companies in the US market operate a concentrated market structure that ...
FTC Chairwoman Lina Khan, with her fellow Democratic Commissioners, recently filed a suit against the leading PBMs in an effort to undermine, or even prohibit, their use of rebates to secure ...
Nationally, criticism of PBM practices intensified over the summer with the FTC report. The PCMA pushed back, saying the ...
Calls for PBM reform focus on transparency and addressing monopolistic practices to improve drug affordability. The FTC's action underscores the need for urgent reforms to address PBMs' anti ...
The Federal Trade Commission (FTC) on September 27, 2024 unexpectedly withdrew from a recently established Memorandum of Understanding (MOU) with ...
Morgan Harper is the director of policy and advocacy and Emma Freer is a senior policy analyst at the American Economic Liberties Project. “I don't know what some of the (patients) are going to ...
The usual PBM strategy cuts an independent pharmacy's share of the prescription revenue to just 3 cents per pill dispensed, ...
One exception that enjoys bipartisan support, however, is the effort to rehab the drug supply chain. It’s currently dominated ...
The PBM profit "is going to line people's pockets ... Bell's Family Pharmacy closed earlier this year. The FTC sued three of the largest PBMs — Caremark, Express Scripts, and Optum Rx, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback